GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (LSE:LEL) » Definitions » Investments And Advances

Eli Lilly and Co (LSE:LEL) Investments And Advances : $3,052 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eli Lilly and Co Investments And Advances?

Eli Lilly and Co's Investments And Advances for the quarter that ended in Dec. 2023 was $3,052 Mil.

Eli Lilly and Co's quarterly Investments And Advances declined from Jun. 2023 ($2,745 Mil) to Sep. 2023 ($2,692 Mil) but then increased from Sep. 2023 ($2,692 Mil) to Dec. 2023 ($3,052 Mil).

Eli Lilly and Co's annual Investments And Advances declined from Dec. 2021 ($3,213 Mil) to Dec. 2022 ($2,902 Mil) but then increased from Dec. 2022 ($2,902 Mil) to Dec. 2023 ($3,052 Mil).


Eli Lilly and Co Investments And Advances Historical Data

The historical data trend for Eli Lilly and Co's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Investments And Advances Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,962.40 2,966.80 3,212.60 2,901.80 3,052.20

Eli Lilly and Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,901.80 2,750.40 2,745.10 2,691.70 3,052.20

Eli Lilly and Co Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Eli Lilly and Co (LSE:LEL) Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (LSE:LEL) Headlines

No Headlines